CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $40,139 | -22.8% | 2,158 | -47.1% | 0.02% | -20.0% |
Q3 2022 | $52,000 | +85.7% | 4,078 | +2.4% | 0.02% | +92.3% |
Q2 2022 | $28,000 | -6.7% | 3,983 | +10.5% | 0.01% | +18.2% |
Q1 2022 | $30,000 | +172.7% | 3,603 | +126.2% | 0.01% | +175.0% |
Q4 2021 | $11,000 | +1000.0% | 1,593 | +1174.4% | 0.00% | – |
Q3 2021 | $1,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |